Poster: MPN-328: Pelabresib (CPI-0610) Improved Anemia Associated with Myelofibrosis: Interim Results from the Ongoing MANIFEST Phase 2 Study
Year: 2021
Type: article
Authors: Prithviraj Bose, Srdan Verstovsek, Marina Kremyanskaya, John Mascarenhas, Moshe Talpaz, Claire Harrison, Raajit Rampal, Andrea Patriarca, Vikas Gupta, Nikki Granacher, Tim Somervaille, Gary Schiller, Mark Drummond, Linda Foltz, Jonathan Lambert, Witold Prejzner, Gozde Colak, Patricia Keller, James Shao, Katarina Luptakova, Ronald Hoffman, Alessandro Vannucchi
Institutions: The University of Texas MD Anderson Cancer Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, University of Michigan, U-M Rogel Cancer Center, Guy's Hospital, St Thomas' Hospital, Memorial Sloan Kettering Cancer Center, Azienda Ospedaliero Universitaria Maggiore della Carita, University of Toronto, Princess Margaret Cancer Centre, Ziekenhuisnetwerk Antwerpen Stuivenberg, University of Manchester, Cancer Research UK Manchester Institute, University of California, Los Angeles, Beatson West of Scotland Cancer Centre, University of British Columbia, St. Paul's Hospital, University College London Hospitals NHS Foundation Trust, Gdańsk Medical University, Constellation Pharmaceuticals (United States), Azienda Ospedaliero-Universitaria Careggi
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4200101132